Related Experiment Video
Updated: Feb 14, 2026

The Serial Anesthesia Array for the High-Throughput Investigation of Volatile Agents Using Drosophila melanogaster
Published on: February 24, 2023
Etomidate derivatives: Novel pharmaceutical agents in anesthesia
Raymond J Malapero1,2, Michael P Zaccagnino1,2, Ethan Y Brovman1,2
1Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Medical School, Boston, MA 02115, USA.
Novel etomidate derivatives offer improved safety and efficacy for anesthesia. Cyclopropyl-methoxycarbonyl metomidate (CPMM) shows promise, particularly for prolonged infusions and reducing inflammatory responses.
Area of Science:
- Anesthesiology and Pharmacology
- Medicinal Chemistry
Background:
- Etomidate, an imidazole anesthetic, has dose-dependent adrenal suppression limiting its use.
- Novel etomidate derivatives are being developed to improve safety and efficacy.
Purpose of the Study:
- To review novel etomidate derivatives with enhanced pharmacological properties.
- To evaluate the safety and clinical potential of these new compounds.
Main Methods:
- Review of pharmacological data and clinical investigations of etomidate derivatives.
- Comparative analysis of etomidate and novel derivatives, including CPMM.
Main Results:
- Cyclopropyl-methoxycarbonyl metomidate (CPMM) exhibits increased potency and reduced metabolite accumulation.
- CPMM demonstrates lower plasma cytokine levels and improved survival in sepsis models compared to etomidate.
Conclusions:
- CPMM presents a favorable safety profile, especially for prolonged anesthesia.
- Further investigation of CPMM is warranted for its potential clinical applications.
More Related Videos
Related Concept Videos
Pharmaceutical Equivalents
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Stages of General Anesthesia
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Poisoning: Treatment Strategies
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

